Filing
Spy
Filing
Spy
Home
About
RCKT
Rocket Pharmaceuticals Inc
Biotechnology company developing gene therapies for rare diseases
CUSIP: 77313F106
Healthcare
US
1 holder
Ownership
Activity
2022 Q4
13 of 19 quarters
Total Value
$66.46M
Total Shares
3.40M
Net Share Change
+863.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Maverick Capital
$66.46M
3.40M
1.6%
ADD
+863.5K
(+34.1%)
Maverick Capital
$66.46M
3.40M shares
ADD
+863.5K
(+34.1%)
RCKT — Rocket Pharmaceuticals Inc - FilingSpy